Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saroj Dhakal

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|September 16, 2025
QPRapp: A Web-Based Platform for PK/PD Simulations and Early Feasibility AnalysisSaroj Dhakal, Yorgos M Psarellis, Nikhil Pillai, et al.
Drug Discovery Today|March 19, 2026
Machine-learning-enabled modeling of pharmacokinetics and pharmacodynamicsYorgos M Psarellis, Nikhil Pillai, Saroj Dhakal, et al.
Scientific Reports|February 5, 2025
Development of an mPBPK machine learning framework for early target pharmacology assessment of biotherapeuticsKrutika Patidar, Nikhil Pillai, Saroj Dhakal, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 24, 2024
A minimal physiologically based pharmacokinetic model to study the combined effect of antibody size, charge, and binding affinity to FcRn/antigen on antibody pharmacokineticsKrutika Patidar, Nikhil Pillai, Saroj Dhakal, et al.
Journal of Medicinal Chemistry|March 27, 2025
Application of Machine Learning and Mechanistic Modeling to Predict Intravenous Pharmacokinetic Profiles in HumansXuelian Jia, Donato Teutonico, Saroj Dhakal, et al.
The Journal of Biological Chemistry|February 17, 2024
E3 ubiquitin ligase rififylin has yin and yang effects on rabbit cardiac transient outward potassium currents (I<sub>to</sub>) and corresponding channel proteinsAnatoli Y Kabakov, Karim Roder, Peter Bronk, et al.
The Journal of Biological Chemistry|October 23, 2020
The endosomal trafficking regulator LITAF controls the cardiac Nav1.5 channel via the ubiquitin ligase NEDD4-2Nilüfer N Turan, Karni S Moshal, Karim Roder, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
CPT: Pharmacometrics & Systems Pharmacology|September 16, 2025
QPRapp: A Web-Based Platform for PK/PD Simulations and Early Feasibility AnalysisSaroj Dhakal, Yorgos M Psarellis, Nikhil Pillai, et al.
Drug Discovery Today|March 19, 2026
Machine-learning-enabled modeling of pharmacokinetics and pharmacodynamicsYorgos M Psarellis, Nikhil Pillai, Saroj Dhakal, et al.
Scientific Reports|February 5, 2025
Development of an mPBPK machine learning framework for early target pharmacology assessment of biotherapeuticsKrutika Patidar, Nikhil Pillai, Saroj Dhakal, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 24, 2024
A minimal physiologically based pharmacokinetic model to study the combined effect of antibody size, charge, and binding affinity to FcRn/antigen on antibody pharmacokineticsKrutika Patidar, Nikhil Pillai, Saroj Dhakal, et al.
Journal of Medicinal Chemistry|March 27, 2025
Application of Machine Learning and Mechanistic Modeling to Predict Intravenous Pharmacokinetic Profiles in HumansXuelian Jia, Donato Teutonico, Saroj Dhakal, et al.
The Journal of Biological Chemistry|February 17, 2024
E3 ubiquitin ligase rififylin has yin and yang effects on rabbit cardiac transient outward potassium currents (I<sub>to</sub>) and corresponding channel proteinsAnatoli Y Kabakov, Karim Roder, Peter Bronk, et al.
The Journal of Biological Chemistry|October 23, 2020
The endosomal trafficking regulator LITAF controls the cardiac Nav1.5 channel via the ubiquitin ligase NEDD4-2Nilüfer N Turan, Karni S Moshal, Karim Roder, et al.
Pageof 1